The partnership forms a cornerstone of “Plan Mexico,” a government-led economic growth strategy designed to attract investment and develop domestic manufacturing capabilities.
Through this collaboration, they will tackle healthcare projects from multiple angles, offering services that span consulting, strategic planning, feasibility assessments, and market and financial studies.
The move positions DHCC as a healthcare destination that’s actively adapting to global shifts in how medical care is delivered and customized.
The announcement comes as part of Dubai’s Economic Agenda D33, which aims to position the emirate as a global healthcare destination.
The healthcare zone centers around Thumbay University Hospital Dubai, which launches in Phase One with specialized services including renal dialysis, cardiology, orthopedics, and rehabilitation.
The acquisition gives Lilly access to Orna’s innovative platform, which combines circular RNA (circRNA) with lipid nanoparticle-based therapies.
The expansion also aligns with the government’s National Cancer Plan for England, which focuses on accelerating patient diagnosis and improving access to treatment nationwide.
The new San Diego facility will function as a critical node in Novartis’s integrated global research network, connecting seamlessly with existing research hubs in Basel, Switzerland, and Cambridge, Massachusetts.
GE HealthCare will join more than 4,300 exhibitors from over 180 countries at this gathering of leading innovators, suppliers, and healthcare professionals.
The new infrastructure enables the organization to procure, store, and rapidly deploy critical medical supplies when outbreaks threaten African communities.